Your browser doesn't support javascript.
loading
Healthcare resource utilization in patients treated with empagliflozin in East Asia.
Sheu, Wayne H-H; Seino, Yutaka; Tan, Elise Chia-Hui; Yabe, Daisuke; Ha, Kyoung Hwa; Nangaku, Masaomi; Chung, Wook-Jin; Node, Koichi; Yasui, Atsutaka; Lei, Wei-Yu; Lee, Sunwoo; Ustyugova, Anastasia; Klement, Riho; Deruaz-Luyet, Anouk; Kyaw, Moe H; Kim, Dae Jung.
Afiliación
  • Sheu WH; Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Seino Y; Kansai Electric Power Medical Research Institute, Kobe, Japan.
  • Tan EC; Kansai Electric Power Hospital, Osaka, Japan.
  • Yabe D; National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan.
  • Ha KH; Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan.
  • Nangaku M; Kansai Electric Power Medical Research Institute, Kobe, Japan.
  • Chung WJ; Department of Diabetes, Endocrinology and Metabolism, and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Node K; Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Yasui A; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.
  • Lei WY; Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan.
  • Lee S; Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • Ustyugova A; Department of Cardiovascular Medicine, Saga University, Saga, Japan.
  • Klement R; Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan.
  • Deruaz-Luyet A; Boehringer Ingelheim Taiwan Ltd, Taipei, Taiwan.
  • Kyaw MH; Boehringer Ingelheim Korea Ltd, Seoul, Korea.
  • Kim DJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
J Diabetes Investig ; 13(5): 810-821, 2022 May.
Article en En | MEDLINE | ID: mdl-34859609
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Prognostic_studies / Systematic_reviews Aspecto: Implementation_research Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Diabetes Investig Año: 2022 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Prognostic_studies / Systematic_reviews Aspecto: Implementation_research Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Diabetes Investig Año: 2022 Tipo del documento: Article País de afiliación: Taiwán